Carbonxt Secures $11 Million Recapitalisation to Fuel Kentucky Facility Ramp-Up
Carbonxt has locked in a $11 million recapitalisation plan with major shareholders to strengthen its balance sheet as its Kentucky activated carbon facility nears commercial production.
- Immediate $3.5 million convertible note subscription
- Debt reduction from $15 million to $10 million
- 10% per annum early-conversion discount on notes and options
- Shareholder approval required at August EGM
- Phelbe and Pure to hold nearly 35% combined post-restructure
Major Shareholders Back $11 Million Recapitalisation
Carbonxt Group Ltd (ASX:CG1) has secured a significant financial lifeline from its two largest stakeholders, Phelbe Pty Ltd and Pure Asset Management, in a two-stage restructuring designed to shore up its balance sheet ahead of commercial production at its Kentucky activated carbon plant. The deal injects a combined $3.5 million immediately through convertible notes, with further equity conversions and debt reduction planned upon facility certification and revenue milestones.
Managing Director Warren Murphy highlighted the timing as ideal, citing stronger operating cash flow and gross margins above 45% underpinning the company’s confidence. “A materially de-geared balance sheet will allow us the flexibility needed to capitalise fully on the significant opportunity in front of us,” Murphy said.
Convertible Notes and Debt Reduction Drive Financial Flexibility
The first stage, already completed, sees Phelbe injecting A$2 million in fresh cash via convertible notes with a 3-year term and 9.5% interest, convertible at A$0.10 per share. Pure Asset Management subscribes for A$1.5 million of notes, set off against existing senior debt and accrued interest. Both parties receive unlisted options exercisable at A$0.10, reinforcing their long-term commitment.
The second stage, contingent on shareholder approval at an Extraordinary General Meeting expected in August and an independent engineer certifying the Kentucky plant operational with at least US$1 million initial revenue, involves Pure exercising warrants and options to reduce senior debt from A$15 million to around A$10 million. Pure will also waive financial covenants on the senior loan until its maturity in May 2027. Concurrently, Phelbe will convert A$2 million of notes to equity and exercise options, raising roughly A$3.4 million in cash.
Incentives to Accelerate Conversion and Simplify Capital Structure
To encourage early conversion and exercise of securities, Carbonxt is offering a 10% per annum discount on convertible notes and options, excluding Pure’s warrants. Even with this discount, conversion prices remain above the current share price of A$0.068, suggesting holders see value in participation. The incentive applies to all option holders and will lapse on 31 December 2026.
If all options holders take up the offer, the company estimates raising approximately A$6 million, which could fund expansion of one of its three facilities or further debt retirement. The restructuring would result in Phelbe and Pure holding approximately 19.6% and 15.7% of Carbonxt respectively, with Phelbe potentially increasing its stake above 20% without triggering a takeover bid.
Kentucky Facility as a Catalyst for Growth
The Kentucky activated carbon facility represents a potential more than doubling of Carbonxt’s group sales capacity. Its commissioning and ramp-up are pivotal to the company’s strategy, expected to drive a material increase in revenues and earnings. This follows a strong run of operational momentum including a 72% revenue surge in Q2 FY26 and positive EBITDA, reflecting growing demand for activated carbon products in industrial pollution control.
The restructuring plan’s combined effect is substantial: an approximate A$11 million cash injection and a net debt reduction of around A$5 million. These moves aim to provide the financial flexibility to capitalise on market opportunities as the Kentucky plant scales production.
Bottom Line?
The success of Carbonxt’s recapitalisation hinges on shareholder approval and Kentucky’s operational certification, setting the stage for a critical inflection point in the company’s growth trajectory.
Questions in the middle?
- Will shareholder support at the August EGM match the confidence shown by major stakeholders?
- How quickly can the Kentucky facility meet the US$1 million revenue milestone to trigger the second stage?
- What impact will the early-conversion incentive have on the company’s share register and liquidity?